Peregrine Pharmaceuticals (PPHM) Soars: Stock Adds 14.5% in Session - Tale of the Tape


Peregrine Pharmaceuticals, Inc. ( PPHM ) was a big mover last session, as the company saw its shares rise over 14% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company as the stock is now up nearly 24% in the past one-month time frame.

The company has seen a mixed track record. There has been one upward revision and one downward revision over the past 30 days, while the Zacks Consensus Estimate has not been in a trend either. Yesterday's price jump is encouraging though, so make sure to keep a close watch on this firm in the near future.

Peregrine Pharmaceuticals currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

However, better-ranked stocks in the biomedicine/gene medical industry include Aastrom Biosciences, Inc. ( ASTM ), Gentium S.p.A ( GENT ) and Heska Corp. ( HSKA ). All these carry a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days . Click to get this free report >>


GENTIUM SPA-ADR (GENT): Free Stock Analysis Report

HESKA CORP (HSKA): Free Stock Analysis Report

PEREGRINE PHARM (PPHM): Free Stock Analysis Report

To read this article on click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.

This article appears in: Investing , Investing Ideas , Stocks

Referenced Stocks: ASTM , GENT , HSKA , PPHM

Find a Credit Card

Select a credit card product by:
Select an offer:
Data Provided by